Their research group injected Ce6-embedded Nano photosensitizing agent (FIC) into the tumor of syngeneic melanoma mice to evaluate the antitumor efficacy and immune response of PDT alone and combined with Rho-kinase (ROCK) inhibitor, which was combined with anti-PD-L1 antibody. Here, CD274 is linked to neoplasm.